Shan Lung Announces Board of Directors' Approval of Q1 2026 Consolidated Financial Report

Shan Lung's Board of Directors approved its Q1 2026 consolidated financial report for the period from January 1 to March 31, 2026. Despite robust operating revenue of NT$1.95 billion, the company reported an operating loss of NT$176.37 million and a basic EPS of -NT$1.37, indicating a challenging quarter.
その他NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 7, 2026 at 09:00
  • 🔍 Collected: May 8, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 8, 2026 at 08:47 (47 min after Collected)
1. Date of reporting to or resolution by the board of directors: 2026/05/07
2. Date of approval by the audit committee: 2026/05/07
3. Reporting period for financial report or annual self-consolidated financial information: 2026/01/01~2026/03/31
4. Operating revenue accumulated from January 1st to the current period (NT$ thousands): 1,958,761
5. Operating gross profit (gross loss) accumulated from January 1st to the current period (NT$ thousands): 146,367
6. Operating income (loss) accumulated from January 1st to the current period (NT$ thousands): -176,379
7. Net profit (net loss) before tax accumulated from January 1st to the current period (NT$ thousands): -182,310
8. Net profit (net loss) for the current period accumulated from January 1st to the current period (NT$ thousands): -185,023
9. Net profit (net loss) attributable to owners of the parent company accumulated from January 1st to the current period (NT$ thousands): -185,776
10. Basic earnings (loss) per share accumulated from January 1st to the current period (NT$): -1.37
11. Total assets at the end of the period (NT$ thousands): 8,337,083
12. Total liabilities at the end of the period (NT$ thousands): 5,710,556
13. Equity attributable to owners of the parent company at the end of the period (NT$ thousands): 2,568,081
14. Other matters to be explained: None